Quinone oxidoreductase-2-mediated prodrug cancer therapy.

Volume:Pages
2(40):40ra50
Site
Pubmed id
20630857
Authors

Middleton MR, Knox R, Cattell E, Oppermann U, Midgley R, Ali R, Auton T, Agarwal R, Anderson D, Sarker D, Judson I, Osawa T, Spanswick VJ, Davies S, Hartley JA, Kerr DJ

DOI
10.1126/scitranslmed.3000615
Journal
Sci Transl Med
Publication Date
2010-7-14
Year
2010
N Publication Date
Validated
Y